Its convenience sets it apart and ensures effective weight management without dietary restrictions
In head-to-head comparisons, tirzepatide produces approximately 5 to 7 percent more total body weight loss than semaglutide at maximum doses
For the first time, scientists put both medications head-to-head in a rigorous clinical trial and in May 2025, the results were published in the New England Journal of Medicine , the most respected medical journal in the world.[1] Here in Shreveport and across northwest Louisiana, where nearly 40% of adults are living with obesity, this study matters
Table S3 The risk of bias for included trials
Compared with liraglutide, more semaglutide users achieved weight loss greater than five or 10 percent
The peptide also reduces inflammation, easing discomfort and helping patients regain movement faster